Market Cap 160.21M
Revenue (ttm) 306.58M
Net Income (ttm) -69.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22.67%
Debt to Equity Ratio 0.44
Volume 688,600
Avg Vol 599,582
Day's Range N/A - N/A
Shares Out 70.73M
Stochastic %K 6%
Beta 1.64
Analysts Sell
Price Target $4.11

Company Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvemen...

Industry: Health Information Services
Sector: Healthcare
Phone: 801 708 6800
Address:
10897 South River Front Parkway, Suite 300, South Jordan, United States
nikitatrades
nikitatrades Nov. 16 at 3:05 PM
šŸ“ˆ William Blair Reiterates Outperform $HCAT šŸš€ āœ… Solid performance and reaffirmed guidance. āœ… Previous quarter's bookings slowdown has stabilized. āœ… Strong margin performance and future profit growth trajectory. āœ… Adjusted EBITDA is expected to reach nearly $60 million by year-end, representing a 50% increase from 2025 guidance levels. āœ… Stock trades at approximately 5 times its 2026 adjusted EBITDA estimate, suggesting significant potential for alpha generation through organic growth and multiple expansion.
0 Ā· Reply
Idvst8
Idvst8 Nov. 13 at 6:45 PM
$HCAT - Holy Hell. This is beaten down HARD
0 Ā· Reply
Idvst8
Idvst8 Nov. 12 at 7:27 PM
$HCAT - Painful. I think this $2.48 level is worth a Nibble. Big DATA at the end of the Day. Not sure if AI can eat their lunch, or not.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 8:23 PM
Citigroup has updated their rating for Health Catalyst ( $HCAT ) to Neutral with a price target of 3.25.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 3:54 PM
Stifel updates rating for Health Catalyst ( $HCAT ) to Hold, target set at 4.5 → 3.75.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 2:30 PM
Wells Fargo updates rating for Health Catalyst ( $HCAT ) to Overweight, target set at 6 → 5.
0 Ā· Reply
d_risk
d_risk Nov. 11 at 12:19 AM
$HCAT - Health Catalyst Inc Common Stock - 10Q - Updated Risk Factors HCAT’s latest 10-Q flags heightened competition from major and niche healthcare tech rivals, industry consolidation, macroeconomic headwinds, restructuring and platform migration risks, talent retention challenges, expanded regulatory and cybersecurity threats, increased debt and compliance burdens, and new ESG and stock dilution concerns—all threatening growth, profitability, and market position. #HealthcareTechnology #StockDilution #ESGConcerns #TalentRetention #CybersecurityThreats #RegulatoryCompliance #MacroeconomicRisks #IndustryConsolidation 🟢 Added 🟠 Removed https://d-risk.ai/HCAT/10-Q/2025-11-10
0 Ā· Reply
RocketThief
RocketThief Oct. 27 at 4:14 PM
$HCAT signs of life the last few weeks…
0 Ā· Reply
Winning_calls
Winning_calls Oct. 20 at 2:35 AM
$HCAT pick me up @ $3.08
0 Ā· Reply
JarvisFlow
JarvisFlow Oct. 8 at 1:18 PM
Evercore ISI Group updates rating for Health Catalyst ( $HCAT ) to In-Line, target set at 4 → 3.
0 Ā· Reply
Latest News on HCAT
Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 10:31 PM EST - 6 days ago

Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript


Health Catalyst Reports Third Quarter 2025 Results

Nov 10, 2025, 4:03 PM EST - 6 days ago

Health Catalyst Reports Third Quarter 2025 Results


Health Catalyst Announces Winners of the 2025 Catalyst Awards

Aug 29, 2025, 9:00 AM EDT - 2 months ago

Health Catalyst Announces Winners of the 2025 Catalyst Awards


Health Catalyst, Inc. (HCAT) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:12 PM EDT - 3 months ago

Health Catalyst, Inc. (HCAT) Q2 2025 Earnings Call Transcript


Health Catalyst Reports Second Quarter 2025 Results

Aug 7, 2025, 4:03 PM EDT - 3 months ago

Health Catalyst Reports Second Quarter 2025 Results


Health Catalyst: Ignite Platform Is A Growth Catalyst

Jun 10, 2025, 5:50 PM EDT - 5 months ago

Health Catalyst: Ignite Platform Is A Growth Catalyst


Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:33 AM EDT - 6 months ago

Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript


Health Catalyst Reports First Quarter 2025 Results

May 7, 2025, 4:03 PM EDT - 6 months ago

Health Catalyst Reports First Quarter 2025 Results


Health Catalyst Announces ~$5 Million Stock Repurchase

Mar 11, 2025, 8:30 AM EDT - 8 months ago

Health Catalyst Announces ~$5 Million Stock Repurchase


Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 11:23 PM EST - 9 months ago

Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript


Health Catalyst Reports Fourth Quarter and Year End 2024 Results

Feb 26, 2025, 4:03 PM EST - 9 months ago

Health Catalyst Reports Fourth Quarter and Year End 2024 Results


Health Catalyst to Participate in Upcoming Investor Conference

Feb 18, 2025, 8:00 AM EST - 9 months ago

Health Catalyst to Participate in Upcoming Investor Conference


Health Catalyst Reports Third Quarter 2024 Results

Nov 6, 2024, 4:03 PM EST - 1 year ago

Health Catalyst Reports Third Quarter 2024 Results


Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 10:39 PM EDT - 1 year ago

Health Catalyst, Inc. (HCAT) Q2 2024 Earnings Call Transcript


Health Catalyst Reports Second Quarter 2024 Results

Aug 7, 2024, 4:13 PM EDT - 1 year ago

Health Catalyst Reports Second Quarter 2024 Results


Time to Play 5 Top-Ranked Stocks With Rising P/E?

Jun 10, 2024, 1:14 PM EDT - 1 year ago

Time to Play 5 Top-Ranked Stocks With Rising P/E?

AMC BNBX XGN YOU


nikitatrades
nikitatrades Nov. 16 at 3:05 PM
šŸ“ˆ William Blair Reiterates Outperform $HCAT šŸš€ āœ… Solid performance and reaffirmed guidance. āœ… Previous quarter's bookings slowdown has stabilized. āœ… Strong margin performance and future profit growth trajectory. āœ… Adjusted EBITDA is expected to reach nearly $60 million by year-end, representing a 50% increase from 2025 guidance levels. āœ… Stock trades at approximately 5 times its 2026 adjusted EBITDA estimate, suggesting significant potential for alpha generation through organic growth and multiple expansion.
0 Ā· Reply
Idvst8
Idvst8 Nov. 13 at 6:45 PM
$HCAT - Holy Hell. This is beaten down HARD
0 Ā· Reply
Idvst8
Idvst8 Nov. 12 at 7:27 PM
$HCAT - Painful. I think this $2.48 level is worth a Nibble. Big DATA at the end of the Day. Not sure if AI can eat their lunch, or not.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 8:23 PM
Citigroup has updated their rating for Health Catalyst ( $HCAT ) to Neutral with a price target of 3.25.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 3:54 PM
Stifel updates rating for Health Catalyst ( $HCAT ) to Hold, target set at 4.5 → 3.75.
0 Ā· Reply
JarvisFlow
JarvisFlow Nov. 11 at 2:30 PM
Wells Fargo updates rating for Health Catalyst ( $HCAT ) to Overweight, target set at 6 → 5.
0 Ā· Reply
d_risk
d_risk Nov. 11 at 12:19 AM
$HCAT - Health Catalyst Inc Common Stock - 10Q - Updated Risk Factors HCAT’s latest 10-Q flags heightened competition from major and niche healthcare tech rivals, industry consolidation, macroeconomic headwinds, restructuring and platform migration risks, talent retention challenges, expanded regulatory and cybersecurity threats, increased debt and compliance burdens, and new ESG and stock dilution concerns—all threatening growth, profitability, and market position. #HealthcareTechnology #StockDilution #ESGConcerns #TalentRetention #CybersecurityThreats #RegulatoryCompliance #MacroeconomicRisks #IndustryConsolidation 🟢 Added 🟠 Removed https://d-risk.ai/HCAT/10-Q/2025-11-10
0 Ā· Reply
RocketThief
RocketThief Oct. 27 at 4:14 PM
$HCAT signs of life the last few weeks…
0 Ā· Reply
Winning_calls
Winning_calls Oct. 20 at 2:35 AM
$HCAT pick me up @ $3.08
0 Ā· Reply
JarvisFlow
JarvisFlow Oct. 8 at 1:18 PM
Evercore ISI Group updates rating for Health Catalyst ( $HCAT ) to In-Line, target set at 4 → 3.
0 Ā· Reply
JarvisFlow
JarvisFlow Oct. 8 at 1:12 PM
Keybanc has adjusted their stance on Health Catalyst ( $HCAT ), setting the rating to Overweight with a target price of 5 → 4.
0 Ā· Reply
JarvisFlow
JarvisFlow Oct. 7 at 1:14 PM
Cantor Fitzgerald has adjusted their stance on Health Catalyst ( $HCAT ), setting the rating to Neutral with a target price of 4.
0 Ā· Reply
Idvst8
Idvst8 Oct. 1 at 5:34 PM
$HCAT - Buy Range.
1 Ā· Reply
JohnMccoy195
JohnMccoy195 Sep. 22 at 6:35 AM
$HCAT Healthcare technology growth. Testing resistance level. Volume confirmation needed. Sector momentum.
0 Ā· Reply
Idvst8
Idvst8 Sep. 17 at 8:42 PM
$HCAT Buying Range. Again. Big Data Again and Again.
1 Ā· Reply
JarvisFlow
JarvisFlow Sep. 5 at 11:00 AM
BTIG updates rating for Health Catalyst ( $HCAT ) to Neutral.
0 Ā· Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 9:49 PM
$HCAT Excellent article that nails exactly where HCAT stands right now. So if you want to update your HCAT knowledge or get acquainted with HCAT, this is a must read. https://beyondspx.com/quote/HCAT/health-catalyst-ignite-fuels-profitable-growth-ambition-amidst-market-evolution-hcat#analysis
0 Ā· Reply
anachartanalyst
anachartanalyst Aug. 29 at 6:02 PM
$HCAT https://anachart.com/wp-content/uploads/ana_temp/1756490540_soc-img.jpg
0 Ā· Reply
DARKP00L
DARKP00L Aug. 29 at 6:02 PM
$HCAT 14:01 on Aug. 29 2025 Canaccord Genuity Maintains Buy on Health Catalyst, Lowers Price Target to $5 #tradeideas
0 Ā· Reply
JarvisFlow
JarvisFlow Aug. 29 at 6:02 PM
Canaccord Genuity updates rating for Health Catalyst ( $HCAT ) to Buy, target set at 9 → 5.
0 Ā· Reply
JarvisFlow
JarvisFlow Aug. 28 at 1:00 PM
Evercore ISI Group updates rating for Health Catalyst ( $HCAT ) to In-Line, target set at 3 → 4.
0 Ā· Reply
DARKP00L
DARKP00L Aug. 27 at 1:21 PM
$HCAT 09:19 on Aug. 27 2025 Piper Sandler Downgrades Health Catalyst to Neutral, Lowers Price Target to $4 #tradeideas
0 Ā· Reply